Applications for our 2026 Accelerator Cohort now Open - APPLY NOW
CancerX Startup Accelerator
The CancerX Accelerator offers startups a unique opportunity to propel their solutions by providing critical resources, support, networking and connections across industry leadership and the public sector through our collaboration with the federal government

Committed Champions Accelerating Growth
Participating startups gain the unique opportunity to be matched with leading healthcare organizations and investors, enabling them to pursue validation, refine their product/market fit, and secure the necessary funding to scale and succeed in the healthcare industry.

Exclusive Mentor
Network
Access a high-engaged mentorship network of doers who are committed to the success of selected startups with deep expertise in digital health and oncology. Benefit from expert guidance, support, and resources throughout the program, helping you navigate the complexities of healthcare innovation.

Network Targeted Programming
We offer startups a customized curriculum designed around your strategic objectives. This programming blends virtual and in-person events to provide valuable opportunities for learning and networking with key stakeholders from both the public and private sectors.
Our Mission
The CancerX Accelerator program catalyzes innovation in cancer research, prevention, and treatment by uniting cross-industry champions, leading investors, and promising startups to accelerate solutions tailored to today’s most urgent challenges in care delivery and patient experiences. By addressing real-world gaps with digital health innovations, these collaborations drive measurable impact for patients, providers, and communities—transforming cancer care together on a relentless quest for better outcomes.
This Year's Cohort Themes
Clinical Trials Reimagined
Modernizing cancer clinical trial access and participation through automated patient matching, digital consent tools, equitable recruitment systems, and data-driven trial infrastructure to increase participation beyond the current 1-in-20 rate.
Care Excellence in Communities
Extending high-quality cancer care from major centers into communities and homes through hospital-at-home models, remote monitoring, and integrated support services to reduce geographic healthcare disparities.
Smart Care Decisions & Operations
Streamlining cancer care through personalized patient engagement, evidence-based decision support at point of care, and operational tools that reduce administrative burdens while improving guideline adherence.
Alignment to Reduce Financial Toxicity
Reducing patient financial toxicity by aligning payor-provider incentives, providing transparent cost information, conducting patient needs assessments, and optimizing care coordination to create sustainable, value-based cancer care.
Your Innovation. Their Lives. Our Mission.
Join the accelerator that's already impacting millions of cancer patients worldwide and be part of our mission to cut cancer deaths by 50%.
Key Dates
2026 Accelerator Applications Open

2026 Accelerator Applications Close

CancerX Accelerator Pitch Week

CancerX 2026 Accelerator Cohort Announcement
.png?width=190&height=200&name=Pitch%20(1).png)
2026 Accelerator Program

2026 Cohort Demo Day Showcase

2027 Accelerator Applications Open

Champions
Meet the organizations that drive the success of CancerX through collaboration and mentorship

.png?width=200&height=60&name=Healio%20logo%20(200%20x%2060%20px).png)
Frequently Asked Questions
Startups eligible for the program must have a validated product or solution ready for scaling, with at least one completed proof of concept (pilot) involving at least 50 patients living with cancer in clinical settings. Your digital solutions must be directly related to one of our four theme areas described above. Companies should have a minimum of 10 full-time employees or equivalent, including a designated liaison to engage with the selection team during the accelerator.
If your application has been selected to advance to the next round, you will be notified by the CancerX Accelerator team in November 2025. Following this, you will be asked to complete a supplemental application and invited to participate in our Pitch Days, which will take place on November 14 and 21, 2025. Detailed instructions will be provided, including what to include in your pitch presentation and how to prepare for the pitch process. If you are not notified by this date, it is possible that you are being considered as an alternate. All applicants will be notified of their final application status by January 2026.
Applications are evaluated based on a combination of factors, including the alignment to the CancerX Accelerator themes, product market fit, the expertise of your founding team, and the impact your startup could have. We also look for innovation, scalability, and your startup’s potential for growth. We require at least two champions to indicate strong interest in your solution to be accepted into the program.
Our four themes for the 2026 Accelerator program are listed above. For more information on these themes, please see details below:
Theme 1: Clinical Trials Reimagined: Access & Research Innovation
Why this matters: Clinical trials are the gateway to tomorrow’s cancer cures—but today fewer than 1 in 20 cancer patients participate. Access is often limited to large academic centers, processes are slow and confusing, and recruitment rarely reflects the diversity of the people cancer impacts. Reimagining trials means accelerating breakthroughs, expanding access, and ensuring every patient—regardless of geography, background, or health literacy—has a fair chance at life-saving innovation.
Key Challenge Areas
- Smarter Patient Matching – Automate and accelerate eligibility checks by linking disparate data sources (EHRs, pathology, genomics, claims) to reduce time and ensure the right patients are identified.
- Trustworthy Consent & Education – Transform how patients and families understand their options with digital tools that make consent clear, human, and empowering.
- Equitable Recruitment at Scale – Support community providers with trial availability databases, decision aids and referral tools so that trial participation is not limited to a few urban centers.
- Research Innovation Infrastructure – Enable data-driven trial design by building tools for real-world evidence integration, biomarker discovery, and novel endpoint measurement.
Theme 2: Bringing Excellence In Cancer Care Closer To Communities
Why this matters: Too often, the quality of cancer care a patient receives depends on where they live. Advanced diagnostics, specialist guidance, and supportive services are concentrated in major cancer centers, leaving rural and underserved patients at risk of worse outcomes. By extending oncology expertise and services into the home and community, we can democratize access to world-class care—improving survival and reducing inequities.
Key Challenge Areas
- Safe oncology-specific hospital-at-home models – Adapt hospital-at-home solutions and infusion protocols safely for cancer treatment.
- Remote monitoring & deterioration prediction – Detect deterioration early and prevent avoidable hospitalizations through biomarkers, wearables, and digital tools.
- Integrated support navigation – Coordinate SDOH needs (transport, housing, food, financial) as part of cancer care through specialized tools.
Theme 3: Smarter Cancer Care Decisions & Operational Excellence
Why this matters: Cancer care today is shaped as much by administrative hurdles as by clinical evidence. Prior authorizations, fragmented data, and documentation burdens consume time that should be spent with patients. At the same time, too many treatment decisions deviate from guidelines or fail to integrate patient values, creating avoidable harm. By uniting smarter decision support with operational excellence, we can ensure every patient receives the right evidence-based care — while reducing friction for clinicians and systems.
Key Challenge Areas
- Personalized patient engagement and outreach – Segment and support patients in ways that improve understanding, adherence, and shared decision-making.
- Guideline concordance at the point of care – Embed evidence-based standards into workflows to reduce unwarranted variation and repetitive testing.
- Operational and data backbone for oncology – Relieve prior auth burden, streamline coverage and revenue-cycle processes, and enable interoperability so care teams can ensure all standard of care has been administered allowing for a focus on patients, not paperwork.
Theme 4: Aligning Payors and Providers to Address Patient Financial Toxicity
Why this matters: Today’s system often rewards high treatment volumes over efficient, high-quality care, driving waste and unsustainable costs. Healthcare stakeholders often lack a deep understanding of patients’ specific needs, limiting personalization that leads to unnecessary spending or denying necessary care prescribed by providers. Digital innovation holds promise to ensure access to quality care and reduce the cost of cancer care. When payors, providers and patients work together and focus on efficiency and value, we can reduce unnecessary dollars spent, ease the financial burden on patients and families, and create a more sustainable, patient-centered model of cancer care.
Key Challenge Areas
- Cost transparency - Provide patients and care partners with cost of care tools to make informed and empowered decisions during treatment planning.
- Patient needs assessment - Use patient engagement tools to better understand patients’ goals and needs in order to tailor supportive services.
- Data driven decision making at the point of care - Empower providers with fair performance data and deeper understanding of their cost and quality metrics to make informed decisions about care delivery.
- Smart care coordination and operational efficiency - Equip cancer centers and provider systems to optimize care delivery, reduce operational waste, and make smarter resource capacity allocation decisions that lower treatment costs while maintaining quality outcomes.
Our 2026 Accelerator program runs from February through June 2026. We will share more details to finalists about in person events, but please expect travel to on-site events roughly each month of the program. The first in person event will be hosted by Moffitt Cancer Center in February (Tampa, FL). Subsequent events will take place in Charlotte, NC, Chicago, IL and Boston, MA. We will confirm final details for you and your team to plan accordingly.
We will also be hosting virtual curriculum sessions once a month across a variety of topics for example: Innovation in Government, Front Lines of Healthcare, Scaling your Business, Partnering with Industry. The CancerX accelerator will send communications for program details once the Accelerator begins.
This is a very hands-on and targeted program and the more you can participate and be involved, the more benefits you will gain for your accelerator experience.
We will work together towards a successful outcome for you during the course of the accelerator but cannot guarantee results.
Our champions are closely involved in the selection process, and the finalists in our 2026 cohort will have at least two champions leaning in to accelerate your company. Each champion will meet with you and discuss goals and approach. Recognize that they are large organizations with many complexities, so be prepared and be patient. The accelerator team is here to help you along the journey.
This year, we are excited to continue our collaboration with KidsX. We are inviting pediatric-focused oncology solutions in the challenge themes above. When you apply, you will select your interest in being considered for the KidsX/CancerX cohort by demonstrating your solutions applicability to the pediatric population. The target patient population for KidsX applications is 0-18 years old.
We welcome your questions. Please email accelerator@cancerx.health
The cohort will be announced in January 2026.
Join the Future of Cancer Innovation
Alumni
Review the organizations who have previously completed our CancerX Accelerator Program
Startups
Meet the finalists driving innovation in the inaugural cohort
















Startups
Meet the 14 finalists driving innovation in last year's cohort
